低滴度O型全血在创伤紧急使用中的安全性及影响
本研究为单中心回顾性分析,纳入2017年11月至2018年6月接受院前或急诊未交叉配血紧急释放血制品的创伤患者,比较接受LTO-WB(198例)与仅接受红细胞和/或血浆(COMP,152例)的患者。LTO-WB组胸部简明损伤定级更高、到达时碱剩余更差、乳酸更高,但急诊后血制品输注更少(中位数0 vs 3,p=0.001)。两组生存率无差异(73% vs 74%,p=0.805),仅COMP组出现2例疑似输血反应(p=0.061),溶血指标无差异。校正年龄、损伤严重度和院前生理后,LTO-WB与急诊后血制品输注减少53%(OR 0.47,95%CI 0.23-0.94,p=0.033)及生存几率提高两倍(OR 2.19,95%CI 1.01-4.76,p=0.047)相关。
要点
- 创伤患者使用LTO-WB与仅用红细胞和/或血浆相比,急诊后血制品输注中位数更少(0 vs 3,p=0.001)。
- 校正年龄、损伤严重度和院前生理后,LTO-WB与急诊后血制品输注减少53%相关(OR 0.47,95%CI 0.23-0.94,p=0.033)。
- 校正后LTO-WB与生存几率提高两倍相关(OR 2.19,95%CI 1.01-4.76,p=0.047),但未校正生存率两组无差异(73% vs 74%,p=0.805)。
- LTO-WB组与COMP组溶血指标无差异,仅COMP组出现2例疑似输血反应(p=0.061)。
- LTO-WB组到达时伤情更重:胸部简明损伤定级中位数3 vs 2(p=0.027),碱剩余-7 vs -5(p=0.014),乳酸5.1 vs 3.5(p<0.001)。
适用人群与场景
- 2017年11月至2018年6月期间在本中心接受院前或急诊未交叉配血、紧急释放血制品输注的创伤患者。
- 分为接受任何LTO-WB的患者和仅接受红细胞和/或血浆(COMP)的患者。
处置流程与药物剂量
- 2017年11月起,本中心将LTO-WB加入每架直升机和急诊科冰箱,与现有红细胞和血浆并存。
- 在3小时、24小时和48小时获取系列溶血面板检测。
研究设计与关键结果
- 研究类型为单中心回顾性分析,纳入198例接受LTO-WB和152例接受COMP的创伤患者。
- 两组年龄、性别和致伤机制无差异;LTO-WB组胸部简明损伤定级更高(中位数3 vs 2,p=0.027),到达时碱剩余更差(中位数-7 vs -5,p=0.014),乳酸更高(5.1 vs 3.5,p<0.001)。
- LTO-WB组急诊后血制品输注中位数少于COMP组(0 vs 3,p=0.001)。
- 生存率两组无差异(LTO-WB 73% vs COMP 74%,p=0.805)。
- 仅COMP组出现2例疑似输血反应(p=0.061),溶血面板值无差异。
- 校正年龄、损伤严重度和院前生理后,LTO-WB与急诊后血制品输注减少53%相关(OR 0.47,95%CI 0.23-0.94,p=0.033),与生存几率提高两倍相关(OR 2.19,95%CI 1.01-4.76,p=0.047)。
证据类型、等级与局限
- 证据类型:治疗性研究,证据等级Level II。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为低滴度O型全血具有相似的实验室溶血证据和相似的输血反应率,并与急诊后输血减少及生存几率提高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Following US military implementation of a cold-stored whole blood program, several US trauma centers have begun incorporating uncrossmatched, group O cold-stored whole blood into civilian trauma resuscitation. We set out to evaluate the safety profile, transfusion reactions events, and impact of low-titer group O whole blood (LTO-WB) at our center.
METHODS: In November 2017, we added LTO-WB to each of our helicopters and to our emergency department (ED) refrigerator, alongside that of existing red blood cells and plasma. We collected information on all patients with trauma receiving prehospital or ED transfusion of uncrossed, emergency release blood products between November 2017 and June 2018. Patients were divided into those receiving any LTO-WB and those receiving only red blood cell and or plasma (COMP). Serial hemolysis panels were obtained at 3 hours, 24 hours, and 48 hours. All data were run using STATA 12.1. Statistical significance was set at p < 0.05.
RESULTS: One hundred ninety-eight patients received LTO-WB and 152 patients received COMP. There were no differences in age, sex, or mechanism. The LTO-WB patients had higher chest Abbreviated Injury Scale scores (median, 3 vs. 2; p = 0.027), as well as worse arrival base excess (median, -7 vs. -5; p = 0.014) and lactate (5.1 vs. 3.5; p < 0.001). The LTO-WB patients received less post-ED blood products than the COMP patients (median, 0 vs. 3; p = 0.001). There was no difference in survival (LTO-WB, 73%; COMP, 74%; p = 0.805). There were only two suspected transfusion reactions, both in the COMP group (p = 0.061). There was no difference in hemolysis panel values. Controlling for age, severity of injury, and prehospital physiology, LTO-WB was associated with a 53% reduction in post-ED blood product transfusion (odds ratio, 0.47; 0.23-0.94 95% CI; p = 0.033) and two-fold increase in likelihood of survival (odds ratio, 2.19; 1.01-4.76 95% CI; p = 0.047).
CONCLUSION: Low-titer group O whole blood has similar evidence of laboratory hemolysis, similar transfusion reaction rates, and is associated with a reduction in post-ED transfusions and increase likelihood of survival.
LEVEL OF EVIDENCE: Therapeutic, Level II.
参考来源
- Williams J, Merutka N, Meyer D, et al. Safety profile and impact of low-titer group O whole blood for emergency use in trauma. J Trauma Acute Care Surg. 2020. PMID: 31464874. doi:10.1097/TA.0000000000002498
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。